NVACR
NorthView Acquisition Corporation [NVACR] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
NVACR Stock Summary
In the News
NVACR Financial details
Company Rating
-
Market Cap
700.45K
Income
1.16M
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
31 Mar 2023
P/E
-9.01
Forward P/E
-
PEG
1.69
P/S
-
P/B
1.54
P/C
-
P/FCF
-98.54
Quick Ratio
3.56
Current Ratio
0.05
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
0.14
EPS next Y
-
EPS next Q
-
EPS this Y
-60%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-165.77%
-
-
-
-
SMA20
100%
SMA50
33.33%
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-11%
ROE
-24%
ROC
-0.13%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.1-0.155
52W High
-
52W Low
-
RSI
66.34
Rel Volume
-
Avg Volume
-
Volume
5K
Perf Week
147.42%
Perf Month
378.09%
Perf Quarter
-
Perf Half Y
60.21%
-
-
-
-
Beta
0.02
-
-
Volatility
0.03%, 0.03%
Prev Close
0%
Price
0.12
Change
0.42%
Company Profile
- Market Capitalization 700.45K
- CEO Mr. Jack E. Stover CPA
- Headquarters New York,NY,US
- IPO Date 2022-01-24
-
Website
https://www.northviewac.com 
NorthView Acquisition Corporation focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other similar business combination with one or more businesses or entities. It intends to focus its search on target businesses in the healthcare sector. The company was incorporated 2021 and is based in New York, New York. NorthView Acquisition Corporation operates as a subsidiary of NorthView Sponsor I, LLC.
